For the full research overview, see the GHK-Cu peptide profile
Medical & Disclaimer Information: Compounded medications offered through NuCore Health have not been reviewed or approved by the FDA for safety, efficacy, or quality
Class II G protein-coupled receptors and their ligands in neuronal function and protection
After your clinical evaluation, your doctor will provide a prescription and advise on the most appropriate formulation based on quality, dosing, and your specific clinical needs
Warning signs that warrant further investigation in the infant with recurrent vomiting include bilious emesis, GI bleeding, onset of vomiting after 6 months, failure to thrive, diarrhea, fever, hepatosplenomegaly, abdominal tenderness or distension, or neurologic changes
In patients whose inflammation is also linked to metabolic issues, we often pair BPC-157 with interventions discussed in our clinical write-up on GHK-Cu and weight loss, which explains how copper peptide signaling integrates with body recomposition goals